Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenny Roose

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Translational Medicine|February 24, 2019
How mRNA therapeutics are entering the monoclonal antibody fieldLien Van Hoecke, Kenny Roose
Vaccines|October 19, 2016
Influenza and Memory T Cells: How to Awake the ForceJan Spitaels, Kenny Roose, Xavier Saelens
Drug News & Perspectives|March 31, 2009
Pandemic preparedness: toward a universal influenza vaccineKenny Roose, Walter Fiers, Xavier Saelens
Expert Review of Vaccines|February 19, 2013
Hepatitis B core-based virus-like particles to present heterologous epitopesKenny Roose, Sarah De Baets, Bert Schepens, et al.
Expert Review of Vaccines|September 12, 2014
Influenza vaccines to control influenza-associated bacterial infection: where do we stand?Ioanna Christopoulou, Kenny Roose, Lorena Itatí Ibañez, et al.
Journal of Visualized Experiments : Jove|May 19, 2017
Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell InfiltrationLien Van Hoecke, Emma Richelle Job, Xavier Saelens, et al.
Journal of Virology|May 17, 2019
Mx1 in Hematopoietic Cells Protects against Thogoto Virus InfectionJan Spitaels, Lien Van Hoecke, Kenny Roose, et al.
Journal of Virology|January 11, 2013
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in miceSarah De Baets, Bert Schepens, Koen Sedeyn, et al.
Vaccine|October 21, 2009
M2e-based universal influenza A vaccineWalter Fiers, Marina De Filette, Karim El Bakkouri, et al.
Plos Pathogens|March 8, 2012
A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infectionJonathan Maelfait, Kenny Roose, Pieter Bogaert, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Translational Medicine|February 24, 2019
How mRNA therapeutics are entering the monoclonal antibody fieldLien Van Hoecke, Kenny Roose
Vaccines|October 19, 2016
Influenza and Memory T Cells: How to Awake the ForceJan Spitaels, Kenny Roose, Xavier Saelens
Drug News & Perspectives|March 31, 2009
Pandemic preparedness: toward a universal influenza vaccineKenny Roose, Walter Fiers, Xavier Saelens
Expert Review of Vaccines|February 19, 2013
Hepatitis B core-based virus-like particles to present heterologous epitopesKenny Roose, Sarah De Baets, Bert Schepens, et al.
Expert Review of Vaccines|September 12, 2014
Influenza vaccines to control influenza-associated bacterial infection: where do we stand?Ioanna Christopoulou, Kenny Roose, Lorena Itatí Ibañez, et al.
Journal of Visualized Experiments : Jove|May 19, 2017
Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell InfiltrationLien Van Hoecke, Emma Richelle Job, Xavier Saelens, et al.
Journal of Virology|May 17, 2019
Mx1 in Hematopoietic Cells Protects against Thogoto Virus InfectionJan Spitaels, Lien Van Hoecke, Kenny Roose, et al.
Journal of Virology|January 11, 2013
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in miceSarah De Baets, Bert Schepens, Koen Sedeyn, et al.
Vaccine|October 21, 2009
M2e-based universal influenza A vaccineWalter Fiers, Marina De Filette, Karim El Bakkouri, et al.
Plos Pathogens|March 8, 2012
A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infectionJonathan Maelfait, Kenny Roose, Pieter Bogaert, et al.
Pageof 4